Importantly, intravenous administration of recombinant uPA (ruPA) after tMCAO reverted the phenotype of uPA−/− but not uPAR−/− animals, indicating that uPA promotes functional improvement following an ischemic stroke, and that this effect is mediated by its binding to uPAR [25]. The gene discussed is PLAUR; the disease is ischemic stroke.